News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
361–396
Matches
1993
Sources here
21
Companies here
23
Search results Stored financial headlines

Active search

1993 matching headlines

Ticker or company: TEXMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

OPTEX SYSTEMS ($OPXS) Releases Q3 2026 Earnings

OPTEX SYSTEMS ($OPXS) released its Q3 2026 earnings, reporting $0.18 per share, missing estimates by $0.05, and revenue of $9.73 million, missing estimates by $2.816 million. Following the announcement, the stock price decreased by 1.82%. The article also details recent insider trading activity, institutional …

OPXS main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% OPXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB reduced its stake in Vertex Pharmaceuticals (NASDAQ:VRTX) by 1.2% in the second quarter, selling 2,555 shares. Despite this, institutional investors collectively own 90.96% of the company, and Wall Street analysts maintain a "Moderate Buy" consensus rating with an average price target …

VRTX main company
Sharemaestro market context Trend signal active 52 weeks +28.0% VRTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Does Terex’s New Shelf Registrations Hint at a Shift in Capital Strategy for TEX?

Terex Corporation recently filed new universal and ESOP-related shelf registrations after reporting Q2 2026 results with increased sales but lower earnings per share. These registrations enhance Terex's financing flexibility by allowing it to issue various securities, potentially reshaping its investment narrative. While the registrations …

TEX main company
Sharemaestro market context Trend signal active 52 weeks +32.9% · Next-week setup negative 43.2% TEX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vertex Pharma stock added to BofA US 1 list of top ideas

Bank of America has added Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) to its US 1 List, highlighting it as a top investment idea. The biotechnology company, with a market cap of $132.79 billion, has shown strong year-to-date and annual performance, despite being considered overvalued by InvestingPro. …

VRTX main company
Sharemaestro market context Trend signal active 52 weeks +28.0% VRTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health (NUTX) Is Up 29.2% After Swinging From Loss To Q2 Profitability - What's Changed

Nutex Health Inc. (NUTX) reported a significant improvement in its Q2 2026 financial results, swinging from a net loss to a net income of US$65.84 million, despite a decline in revenue. This shift has led to a 29.2% increase in its stock price and …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Instruments Incorporated $TXN Shares Purchased by Carolina Wealth Advisors LLC

Carolina Wealth Advisors LLC significantly increased its stake in Texas Instruments (NASDAQ:TXN) by 57.9% in the second quarter, making the semiconductor company its 9th largest holding. Other institutional investors also adjusted their positions in TXN. The article also details recent analyst rating changes, insider …

TXN main company
Sharemaestro market context Trend signal active 52 weeks +38.5% TXN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ETFs Investing in Vertex, Inc. Class A Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Vertex, Inc. Class A stocks. It provides detailed information for each ETF, including market value, weight, issuer, management style, focus, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV total return. The …

VERX main company
Sharemaestro market context Price below Trend Line 52 weeks -50.8% VERX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Average basic shares outstanding of Vertex, Inc. Class A – HAM:56X

This article provides a financial data point for Vertex, Inc. Class A (HAM:56X) on the Hamburg Stock Exchange, specifically its average basic shares outstanding. It lists various sections related to financial information, community, and company details without presenting detailed figures for the shares outstanding. …

VERX main company
Sharemaestro market context Price below Trend Line 52 weeks -50.8% VERX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ausbil Investment Management Ltd Acquires New Position in Texas Roadhouse, Inc. $TXRH

Ausbil Investment Management Ltd has acquired a new position in Texas Roadhouse, Inc., purchasing 8,025 shares valued at approximately $1.54 million during the second quarter. The restaurant operator reported strong quarterly results, beating analyst expectations with $1.85 EPS and $1.68 billion in revenue, an …

TXRH main company
Sharemaestro market context Trend signal active 52 weeks +18.8% · Next-week setup positive 58.9% TXRH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vertex Pharmaceuticals (VRTX) legt um 11,3 % zu, nachdem das Unternehmen seine Umsatzprognose für 2026 angehoben und den Ausblick für den Cashflow angepasst hat – Hat sich das bullische Szenario geändert?

VX1 main company VRTX main company
Sharemaestro market context Trend signal active 52 weeks +28.3% VX1 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vertex Pharmaceuticals (VRTX) Is Up 11.3% After Raising 2026 Revenue Guidance And CF Outlook Shift – Has The Bull Case Changed?

Vertex Pharmaceuticals reported strong Q2 2026 results, raising its full-year 2026 revenue guidance to US$13.1 billion to US$13.2 billion and benefiting from reduced competition in cystic fibrosis. The company also entered a collaboration with AbCellera Biologics to expand its portfolio beyond CF into areas …

VRTX main company VERX main company
Sharemaestro market context Trend signal active 52 weeks +28.0% VRTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

VERTEX PHARMACEUTICALS INCORPORATED : JEFFERIES RAISES TARGET PRICE TO $633 FROM $610

Jefferies has raised its target price for VERTEX PHARMACEUTICALS INCORPORATED (VRTX.O) to $633 from $610. The article, published by Reuters, indicates this adjustment in the target price for the pharmaceutical company's stock. It also includes a disclaimer stating that the content reflects the author's …

VRTX main company
Sharemaestro market context Trend signal active 52 weeks +28.0% VRTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Community Bancshares (NASDAQ:TCBS) Stock Price Down 1% - Here's Why

Texas Community Bancshares (NASDAQ:TCBS) saw its stock price drop by 1% to $17.26 on Monday, with trading volume consistent with its average. The company, which has a market capitalization of approximately $49.9 million, recently increased its quarterly dividend to $0.06 per share and analysts …

TCBS main company
Sharemaestro market context Trend signal active 52 weeks +9.3% TCBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vertex (VERX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Monday, Aug. 3, 2026 at 5 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Joseph CrivelliPresident and Chief Executive Officer - Christopher YoungChief Financial Officer - John Schwab TAKEAWAYS Total Revenue -- Vertex, Inc.(NASDAQ:VERX) reported revenue …

VERX main company
Sharemaestro market context Price below Trend Line 52 weeks -50.8% VERX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Instruments’ Earnings Just Exposed AI’s Copper Problem

Texas Instruments' Q2 2026 earnings revealed a critical, often-overlooked challenge in the AI industry: the physical limitations of power delivery to server racks, primarily due to Ohm's law and the high current demands of increasingly powerful GPUs. The article explains how traditional 54V distribution …

TXN main company
Sharemaestro market context Trend signal active 52 weeks +38.5% TXN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GNTX Maintained by JP Morgan -- Price Target Lowered to $27.00

JP Morgan analyst Rajat Gupta maintained a neutral rating for Gentex (GNTX) but lowered its price target to $27.00 from $28.00. Despite this, GuruFocus assesses GNTX as undervalued by 28.8% with a strong GF Score of 92/100, driven by excellent financial strength and profitability. …

GNTX main company
Sharemaestro market context Trend signal active 52 weeks -14.0% GNTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Instruments Inc. stock outperforms competitors despite losses on the day

Shares of Texas Instruments Inc. fell by 1.97% to $280.44 on Monday, despite the stock outperforming competitors. The decline occurred during a tough trading session where both the S&P 500 Index and Dow Jones Industrial Average also saw losses. This drop ended a two-day …

TXN main company
Sharemaestro market context Trend signal active 52 weeks +38.5% TXN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Textron Aviation files plans for $24.5M in renovations to Wichita campuses

Textron Aviation is investing $24.5 million in renovations across its Wichita manufacturing campuses, including a $16 million corridor reconstruction project. The company, which employs 11,000 workers locally, is undertaking these upgrades as part of its ongoing commitment to its facilities.

TXT main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% · Next-week setup positive 55.4% TXT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

JPMorgan Chase & Co. Lowers Gentex (NASDAQ:GNTX) Price Target to $27.00

JPMorgan Chase & Co. has reduced its price target for Gentex (NASDAQ:GNTX) to $27.00 from $28.00, while maintaining a "neutral" rating. This new target implies a potential upside of 13.23% from the stock's previous close. Despite beating EPS expectations with $0.58, Gentex's revenue of …

GNTX main company
Sharemaestro market context Trend signal active 52 weeks -14.0% GNTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Horizon Kinetics Asset Management buys $353 in Texas Pacific Land shares

Horizon Kinetics Asset Management LLC, a significant shareholder in Texas Pacific Land Corp (TPL), recently purchased additional shares worth $353 at $353.28 each. This transaction occurred after TPL's stock had declined by 16% over the past week and is trading significantly below its 52-week …

TPL main company
Sharemaestro market context Price below Trend Line 52 weeks +18.7% TPL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health jumps 21%, continuing post-earnings run (NUTX:NASDAQ)

Nutex Health (NUTX) shares surged nearly 21% on Monday, extending a previous 7% gain after the company's second-quarter earnings release. The stock's recent performance is attributed to strong Q2 earnings, significant net income improvement, and cost reductions, despite a revenue miss. The company's earnings …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Pacific Land Corp (TPL) major holder logs small open-market share purchase

Horizon Kinetics Asset Management LLC, a significant holder of Texas Pacific Land Corp (TPL), reported a small open-market purchase of 1 common stock share at $353.28 on August 7, 2026. This transaction brings its direct holdings to 3,244,005 shares. A footnote clarifies that the …

TPL main company
Sharemaestro market context Price below Trend Line 52 weeks +18.7% TPL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TEXAS ROADHOUSE INC : PIPER SANDLER RAISES TARGET PRICE TO $208 FROM $192

Piper Sandler has increased its target price for Texas Roadhouse Inc (TXRH.O) to $208 from $192. This news was reported by Reuters on August 10, 2026. The article states that this information reflects the author's opinion and is not intended as investment advice.

TXRH main company
Sharemaestro market context Trend signal active 52 weeks +18.8% · Next-week setup positive 58.9% TXRH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wall Street Analysts Are Neutral on Top Healthcare Picks

Wall Street analysts have issued neutral ratings for Vertex Pharmaceuticals (VRTX) and Travere Therapeutics (TVTX), indicating that experts are neither bullish nor bearish on these healthcare stocks. Stifel Nicolaus analysts maintained Hold ratings for both companies, with specific price targets set. Despite these neutral …

VRTX main company
Sharemaestro market context Trend signal active 52 weeks +28.0% VRTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context